Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | glutathione reductase, putative | 0.0054 | 0.3888 | 0.5 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0095 | 1 | 1 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0054 | 0.3888 | 0.2536 |
Plasmodium falciparum | thioredoxin reductase | 0.0054 | 0.3888 | 0.2536 |
Plasmodium falciparum | thioredoxin reductase | 0.0095 | 1 | 1 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.0054 | 0.3888 | 0.2536 |
Loa Loa (eye worm) | histone deacetylase | 0.004 | 0.1812 | 0.1812 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0054 | 0.3888 | 0.2536 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0054 | 0.3888 | 0.2536 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0054 | 0.3888 | 0.2536 |
Echinococcus multilocularis | histone deacetylase 6 | 0.0047 | 0.2735 | 0.1128 |
Plasmodium falciparum | glutathione reductase | 0.0054 | 0.3888 | 0.2536 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0054 | 0.3888 | 0.2536 |
Treponema pallidum | NADH oxidase | 0.0054 | 0.3888 | 0.5 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0095 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0923 | 0.0923 |
Toxoplasma gondii | thioredoxin reductase | 0.0095 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0054 | 0.3888 | 0.5 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0054 | 0.3888 | 0.5 |
Echinococcus granulosus | histone deacetylase 6 | 0.0047 | 0.2735 | 0.1128 |
Leishmania major | trypanothione reductase | 0.0095 | 1 | 1 |
Schistosoma mansoni | histone deacetylase hda2 | 0.0047 | 0.2735 | 0.1128 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0054 | 0.3888 | 0.2603 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0095 | 1 | 1 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0054 | 0.3888 | 0.2536 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0054 | 0.3888 | 0.2536 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0054 | 0.3888 | 0.5 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0054 | 0.3888 | 0.2536 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0054 | 0.3888 | 0.2536 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.0054 | 0.3888 | 0.2536 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0054 | 0.3888 | 0.5 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.0054 | 0.3888 | 0.2536 |
Brugia malayi | Histone deacetylase family protein | 0.004 | 0.1812 | 0.009 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.0054 | 0.3888 | 0.2536 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0054 | 0.3888 | 0.2536 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0095 | 1 | 1 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0054 | 0.3888 | 0.5 |
Loa Loa (eye worm) | histone deacetylase 7A | 0.004 | 0.1812 | 0.1812 |
Plasmodium vivax | glutathione reductase, putative | 0.0095 | 1 | 1 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0054 | 0.3888 | 0.2536 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0054 | 0.3888 | 0.5 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0054 | 0.3888 | 0.2536 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0095 | 1 | 1 |
Brugia malayi | Histone deacetylase family protein | 0.004 | 0.1812 | 0.009 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0054 | 0.3888 | 0.2536 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.0054 | 0.3888 | 0.2536 |
Loa Loa (eye worm) | glutathione reductase | 0.0095 | 1 | 1 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0054 | 0.3888 | 0.5 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0054 | 0.3888 | 0.5 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0054 | 0.3888 | 0.5 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.0054 | 0.3888 | 0.2536 |
Plasmodium falciparum | glutathione reductase | 0.0095 | 1 | 1 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0095 | 1 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0095 | 1 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0054 | 0.3888 | 0.2536 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0054 | 0.3888 | 0.2536 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0054 | 0.3888 | 0.2536 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0054 | 0.3888 | 0.2536 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0054 | 0.3888 | 0.2536 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0054 | 0.3888 | 0.2536 |
Brugia malayi | Thioredoxin reductase | 0.0095 | 1 | 1 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0054 | 0.3888 | 0.2536 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.